| P2093 | author name string | M H De Baets | |
| P2860 | cites work | The nature of the thyroid auto-antibodies present in patients with Hashimoto's thyroiditis (lymphadenoid goitre) | Q24531106 |
| | Direct demonstration that receptor crosslinking or aggregation is important in insulin action | Q24616924 |
| | Towards a network theory of the immune system. | Q34202813 |
| | CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE | Q34410004 |
| | Antibodies That Impair Insulin Receptor Binding in an Unusual Diabetic Syndrome with Severe Insulin Resistance | Q34576999 |
| | Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence | Q34707676 |
| | Structural homology of Torpedo californica acetylcholine receptor subunits | Q34707687 |
| | Evolution of studies on antireceptor antibodies and disease | Q67271173 |
| | Ganglioside dependent return of TSH receptor function in a rat thyroid tumor with a TSH receptor defect | Q67283401 |
| | Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera | Q67344915 |
| | Acetylcholine receptor antibody in myasthenia gravis: purification and characterization | Q67432537 |
| | Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease | Q67771513 |
| | Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies | Q68812470 |
| | Receptor aggregation is necessary for activation of the soluble insulin receptor kinase | Q68857440 |
| | Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera | Q70061647 |
| | Biological activities of binding site specific monoclonal antibodies to prolactin receptors of rabbit mammary gland | Q70101350 |
| | Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors | Q70194705 |
| | Acquired Iron-Deficiency Anemia Caused by an Antibody against the Transferrin Receptor | Q70220017 |
| | Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin | Q70227993 |
| | The influence of HLA phenotypes on the response to parenteral gold in rheumatoid arthritis | Q70303966 |
| | Kinetic Differences in Unresponsiveness of Thymus and Bone Marrow Cells | Q70548512 |
| | Visualization of the insulin receptor by immunoblotting | Q70617844 |
| | Reactions among IgM antibodies derived from normal, neonatal mice | Q71008195 |
| | Induction of autoantibodies to thyroglobulin by anti-idiotypic antibodies | Q71008573 |
| | Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis | Q71012142 |
| | Inhibition of adenylate cyclase activity of human thyroid membranes by gangliosides | Q71269903 |
| | The thyroid-stimulating properties of long-acting thyroid stimulator γG-globulin subunits | Q71286635 |
| | Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor | Q71550431 |
| | Prediction of relapse in hyperthyroid Graves' disease | Q72423529 |
| | Acquired iron-deficiency anaemia due to impaired iron transport | Q72542141 |
| | Identification of exposed and buried determinants of the membrane-bound acetylcholine receptor from Torpedo californica | Q72649006 |
| | Organization of ligand binding sites at the acetylcholine receptor: a study with monoclonal antibodies | Q72697392 |
| | High degree of idiotypic cross-reactivity among murine monoclonal antibodies to thyroglobulin | Q72715117 |
| | Familial Neonatal Transient Hypothyroidism Due to Maternal TSH-Binding Inhibitor Immunoglobulins | Q72859927 |
| | Autonomic abnormalities and autoantibodies to beta-adrenergic receptors | Q72909798 |
| | Inhibition of Follicle-Stimulating Hormone Receptor Binding by CirculatingImmunoglobulins* | Q72929958 |
| | Thyroid gangliosides with high affinity for thyrotropin: potential role in thyroid regulation | Q80479322 |
| | Regulatory idiotopes and immune networks: a hypothesis | Q85699048 |
| | Primary structures of beta- and delta-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences | Q34712212 |
| | Modulation of acetylcholine receptor by antibody against the receptor | Q35039206 |
| | Structure and transmembrane nature of the acetylcholine receptor in amphibian skeletal muscle as revealed by cross-reacting monoclonal antibodies | Q36209933 |
| | Monoclonal antibodies detect the conservation of muscarinic cholinergic receptor structure from Drosophila to human brain and detect possible structural homology with alpha 1-adrenergic receptors | Q36246160 |
| | Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies | Q36275255 |
| | Molecular cloning of cDNA coding for the gamma subunit of Torpedo acetylcholine receptor | Q36305249 |
| | Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease | Q36319258 |
| | Autoantibodies of various specificities encoded by genes from the VH J558 family bind to foreign antigens and share idiotopes of antibodies specific for self and foreign antigens | Q36354033 |
| | Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor | Q36383082 |
| | Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase | Q36419578 |
| | Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody | Q37315425 |
| | Use of anti-idiotypic antibodies as cell-surface receptor probes | Q37586987 |
| | Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor | Q37593241 |
| | Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia | Q37616547 |
| | The atomic mobility component of protein antigenicity | Q38154881 |
| | Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome | Q39497590 |
| | Autoantibodies to parathyroid hormone receptor | Q39520614 |
| | The Biology and Detection of Immune Complexes | Q39590911 |
| | Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis | Q39829067 |
| | The antigenic structure of proteins: a reappraisal. | Q40076398 |
| | Antigen-Presenting Function of the Macrophage | Q40119147 |
| | Anti-idiotype and anti-hormone receptor antibodies | Q40136924 |
| | Autoantibodies to β2-Adrenergic Receptors: a Possible Cause of Adrenergic Hyporesponsiveness in Allergic Rhinitis and Asthma | Q40862381 |
| | Naturally occurring autologous anti-idiotypic antibodies. Participation in immune complex formation in selective IgA deficiency | Q42936081 |
| | Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line | Q43684259 |
| | Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping | Q43725366 |
| | Perturbation of the autoimmune network. II. Immunization with isologous idiotype induces auto-anti-idiotypic antibodies and suppresses the autoantibody response elicited by antigen: a serologic and cellular analysis | Q44186741 |
| | Myasthenic immunoglobulin accelerates acetylcholine receptor degradation | Q44594534 |
| | Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor | Q44826205 |
| | Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domain | Q45142312 |
| | Various expressions of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease. | Q45895429 |
| | Thyroid-stimulating immunoglobulins in Graves' disease | Q46966821 |
| | The Immunoglobulin G (IgG) of Graves’ Disease: Thyroid Stimulation by Fraction and Fragment | Q47798737 |
| | Autoimmune Response to Acetylcholine Receptor | Q47996933 |
| | Hypoglycemia associated with antibodies to the insulin receptor. | Q51648918 |
| | Monoclonal antibodies to cytoplasmic domains of the acetylcholine receptor | Q52826144 |
| | Inhibition of parietal cell function by human gammaglobulin containing gastric parietal cell antibodies. | Q53959487 |
| | Presence of gangliosides in the structure of membrane receptor for thyrotrophin | Q54242841 |
| | Stimulation of the human thyroid by infusions of plasma containing LATS protector. | Q54661203 |
| | Thyroid growth-blocking antibodies in primary myxoedema | Q59061454 |
| | Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients | Q59071320 |
| | Binding sites for lactogenic and somatogenic hormones from rabbit mammary gland and liver | Q67246458 |
| P433 | issue | 3 | |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 218-231 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Specificities of autoantibodies in autoimmune receptor diseases | |
| P478 | volume | 7 | |